SYK

Stryker Corporation

NYQ · Healthcare

$269.75

-$3.65 (-1.34%)down -1.34%

24 September 2026 · delayed 15+ min

F

Quality score54.0 / 100

Cut-offs are the grader's own: 97+ for an A+, below 60 is an F.

Stryker Corporation earns a F on good profit margins (>10%) and strong current ratio (>2.0) but high debt-to-equity ratio (>2.0) and price well below 200-day SMA (downtrend). Consider alternatives with better risk/reward profiles.

Model stance WEAK HOLD Suggested position 4.0% · $400.00 IQInvest estimate
Adjusted for Moderate investors, Medium-term investors 4.0% suggested allocation Change these

These change the suggested position size and the stance, not the category scores. Amount is in dollars.

IQ-SYK-20260924engine v1 · 7-category weighted scorecard

What it is worth, depending who you ask.

Today’s price against the year it has had and the targets analysts publish. Every marker is a reported figure, not a projection of ours.

52-week low

$267.00

Today's price

$269.75

Lowest analyst target

$298.00

Mean analyst target

$369.00

52-week high

$392.55

Highest analyst target

$465.00

SYK trades 2% of the way up its 52-week range, between $267.00 and $392.55. The mean analyst target of $369.00 is 36.8% above today's price.

Today’s price 52-week range Analyst price targets

Scored categories

Financial healthGood profit margins (>10%); Strong current ratio (>2.0); High debt-to-equity ratio (>2.0) 100.023%

Profit margin

14.43%

Net profit per unit of revenue

healthyWhat this means

Of every 100 units of revenue, this much survives as profit.

A comfortable buffer between revenue and costs.

Operating margin

27.02%

Before interest and tax

very highWhat this means

Profit from operations, before interest and tax, per 100 of revenue.

Typical of software and other businesses with little cost per extra sale.

Gross margin

65.59%

After the cost of goods only

highWhat this means

What is left of revenue after only the direct cost of the product.

Little marginal cost per sale, which is what lets software and pharma fund heavy R&D.

Return on equity

16.51%

Profit per unit of shareholder capital

strongWhat this means

Profit generated per unit of shareholder capital.

Above 15% is generally considered a good business.

Return on assets

8.16%

Profit per unit of assets

strongWhat this means

Profit generated per unit of everything the company owns.

The assets are working hard.

Debt to equity

64.39

Borrowings against equity

moderateWhat this means

Borrowings measured against shareholder capital.

Normal for most established companies.

Current ratio

2.16

Short-term assets over short-term debts

very liquidWhat this means

Short-term assets against short-term obligations.

Plenty of cover, though idle cash earns little.

Quick ratio

1.08

As above, excluding inventory

comfortableWhat this means

Short-term assets excluding inventory, against short-term debts.

Liquid assets exceed short-term obligations.

Revenue growth

9.40%

Year on year

growingWhat this means

Change in revenue against the same period last year.

A healthy expansion rate.

Earnings growth

44.10%

Year on year

very strongWhat this means

Change in earnings against the same period last year.

Check whether it is repeatable or a one-off — a single asset sale can flatter this badly.

Revenue

$12.61B

Trailing twelve months

Free cash flow

$4.11B

Cash left after capital spending

Operating cash flow

$5.53B

Cash from the business itself

Payout ratio

36.06%

Dividends as a share of earnings

conservativeWhat this means

The share of earnings paid out as dividends.

Comfortably covered, with room to keep raising it.

Growth & momentumPoor 1-year return (-27.0%); Low Sharpe ratio (0.08) 0.022%

Return, 1 month

-18.40%

Return, 3 months

-14.44%

Return, 6 months

-17.23%

Return, year to date

-22.11%

Return, 1 year

-27.05%

Return, 3 years

-5.43%

Sharpe ratio

0.08

Return earned per unit of risk

modestWhat this means

Return earned per unit of risk taken.

Below 1 is the common case; return did not strongly outpace the volatility.

Win rate

49.84%

Share of days that closed up

about evenWhat this means

The share of trading days that closed higher.

Close to a coin flip, which is the norm — returns come from the size of moves, not their count.

Average daily return

0.02%

Best day

9.91%

Worst day

-8.81%

Valuation9 measured figures 50.018%

P/E ratio

27.95

Price against trailing earnings

highWhat this means

You pay 27.95 for every 1 unit of annual earnings.

Above about 25 the market is paying up for expected growth.

Forward P/E

16.13

Price against forecast earnings

moderateWhat this means

Price against next year's *forecast* earnings.

A conventional range.

PEG ratio

1.28

P/E adjusted for growth

fairWhat this means

P/E divided by the growth rate — it asks whether the price is justified by the growth.

Between 1 and 2 price and growth are roughly in step.

Price to book

4.31

Price against balance-sheet equity

well above bookWhat this means

Price against the accounting value of the company's net assets.

Normal for asset-light businesses, where the value sits in brands and software the balance sheet never records.

Price to sales

4.00

Price against revenue

highWhat this means

Price against revenue — usable when a company has no profit yet.

The price assumes today's revenue will convert into much more profit later.

EV / EBITDA

15.84

Whole-company value against cash earnings

highWhat this means

Whole-company value, debt included, against cash earnings.

Expensive even before interest, tax and depreciation are considered.

Enterprise value

$116.84B

Market value plus debt, minus cash — the price of the whole business

Shares outstanding

383,573,046

Shares the profit is split across

Dividend yield

1.29%

Annual dividend against price

modestWhat this means

Annual dividend as a percentage of the share price.

A small income component.

TechnicalStrong trend (ADX > 25); RSI oversold (<30) - potential buying opportunity; Price well below 200-day SMA (downtrend); MACD bearish (negative histogram) 40.015%

RSI (14)

28.9

Above 70 overbought, below 30 oversold

oversoldWhat this means

A 0–100 momentum gauge over the last 14 sessions.

Below 30 conventionally reads as oversold, and traders watch for a bounce — a convention, not a law.

MACD

-14.20

Momentum against its own trend

MACD histogram

-1.01

Positive is bullish

ADX

29.3

Trend strength; above 25 is a real trend

trendingWhat this means

Trend strength, regardless of direction.

Above 25 is conventionally read as a genuine trend in force.

20-day average

$293.26

50-day average

$317.30

200-day average

$331.91

Price vs 50-day

-14.98%

Price vs 200-day

-18.73%

Bollinger upper

$336.51

Bollinger lower

$250.00

Average true range

8.96

Typical daily trading range

Stochastic %K

5.2

Risk4 measured figures 50.012%

Volatility, annualised

25.69%

How far it swings in a year

normalWhat this means

How far the price typically swings over a year.

A typical range for an individual share.

Beta

0.77

Moves against the wider market

steadier than the marketWhat this means

How much the price moves relative to the wider market.

Tends to move less than the index, in both directions.

Maximum drawdown

-32.47%

Worst peak-to-trough fall

significantWhat this means

The worst peak-to-trough fall in the period measured.

A serious decline, though not unusual over a multi-year window.

Risk category

High

The engine's own banding

Analyst viewAnalyst consensus: Buy; Significant upside potential (36.8%) 100.010%

Consensus

Buy

What covering analysts rate it

Analysts covering

25

Mean price target

$369.00

Highest target

$465.00

Lowest target

$298.00

Implied upside

36.79%

Target against today's price

largeWhat this means

How far the mean analyst target sits above today's price.

A wide gap, which as often means the price has fallen as that the target is right.

Price against the S&P 500

180 trading days to 2026-09-24

SYK is 26.0% down over the window, against 10.9% up for the S&P 500 — behind by 36.9 points.
SYK -26.0%S&P 500 +10.9%
Show the numbers
Sampled across the window. Both columns are rebased to 100 on 2026-01-06, so they can be compared directly.
DateCloseSYK rebasedS&P 500 rebased
2026-01-06$364.43100.0100.0
2026-01-28$355.9197.7100.5
2026-02-19$370.66101.798.8
2026-03-12$335.4092.096.1
2026-04-02$330.6690.794.8
2026-04-24$326.6489.6103.2
2026-05-15$305.9484.0106.7
2026-06-08$300.7382.5106.6
2026-06-30$314.8486.4108.0
2026-07-22$309.2484.9108.0
2026-08-12$347.2195.3111.6
2026-09-02$312.1985.7110.4

How the score was built

Each category is scored 0–100, then multiplied by its weight. The seven contributions sum to the quality score.
CategoryScoreWeightContribution
Financial health100.023%23.0
Growth & momentum0.022%0.0
Valuation50.018%9.0
Technical40.015%6.0
Risk50.012%6.0
Analyst view100.010%10.0
ESG50.00%0.0
Quality score100%54.0

ESG is scored but carries no weight in this grade. Add ?esg=1 to the address to include it — the engine then redistributes weight across the other six, so the whole scorecard changes, not just one row.

Argue with the model

Every other grader hands you a number. This one hands you the model.

Move a slider, press Recalculate, and the grade is rebuilt from the same category scores. Nothing is hidden: the scores are the engine's, only the weighting is yours.

What each model believes. Pick one above, or set your own sliders below.
ModelThe emphasis
IQInvest defaultThe engine's own weighting: financial health 23% and performance 22% lead, valuation 18%, then technicals, risk and analysts.
Value investorPrice against worth dominates: valuation 40%, financial health 25%. Chart signals count for almost nothing.
Growth investorMomentum first: performance 40% and technicals 20%. Whether the price is fair today gets just 5%.
Sleep at nightStability over everything: risk 35% and financial health 30% together outweigh all other categories combined.
ChartistThe tape over the fundamentals: technicals 45% and performance 25%. Valuation is nearly ignored.
18%
23%
22%
12%
15%
10%
0%

These are IQInvest's own weights, totalling 100%.

Your grade

F

54.0 / 100

Identical to the IQInvest grade.

All 66 metricsOne flat sortable table, for when you want everything at once.
Metric Category Value Source
20-day averageTechnical$293.26Yahoo Finance
200-day averageTechnical$331.91Yahoo Finance
50-day averageTechnical$317.30Yahoo Finance
52-week highMarket data$392.55Yahoo Finance
52-week lowMarket data$267.00Yahoo Finance
ADXTechnical29.3Yahoo Finance
Analysts coveringAnalyst view25Yahoo Finance
Average daily returnGrowth & momentum0.02%Yahoo Finance
Average true rangeTechnical8.96Yahoo Finance
Average volumeMarket data2,677,106Yahoo Finance
Best dayGrowth & momentum9.91%Yahoo Finance
BetaRisk0.77Yahoo Finance
Bollinger lowerTechnical$250.00Yahoo Finance
Bollinger upperTechnical$336.51Yahoo Finance
ConsensusAnalyst viewBuyYahoo Finance
Current ratioFinancial health2.16Yahoo Finance
Day highMarket data$275.71Yahoo Finance
Day lowMarket data$269.73Yahoo Finance
Debt to equityFinancial health64.39Yahoo Finance
Dividend yieldValuation1.29%Yahoo Finance
Earnings growthFinancial health44.10%Yahoo Finance
EmployeesMarket data56,000Yahoo Finance
Enterprise valueValuation$116.84BYahoo Finance
EV / EBITDAValuation15.84Yahoo Finance
Forward P/EValuation16.13Yahoo Finance
Free cash flowFinancial health$4.11BYahoo Finance
Gross marginFinancial health65.59%Yahoo Finance
Highest targetAnalyst view$465.00Yahoo Finance
Implied upsideAnalyst view36.79%Yahoo Finance
Lowest targetAnalyst view$298.00Yahoo Finance
MACDTechnical-14.20Yahoo Finance
MACD histogramTechnical-1.01Yahoo Finance
Maximum drawdownRisk-32.47%Yahoo Finance
Mean price targetAnalyst view$369.00Yahoo Finance
OpenMarket data$273.22Yahoo Finance
Operating cash flowFinancial health$5.53BYahoo Finance
Operating marginFinancial health27.02%Yahoo Finance
P/E ratioValuation27.95Yahoo Finance
Payout ratioFinancial health36.06%Yahoo Finance
PEG ratioValuation1.28Yahoo Finance
Previous closeMarket data$273.40Yahoo Finance
Price to bookValuation4.31Yahoo Finance
Price to salesValuation4.00Yahoo Finance
Price vs 200-dayTechnical-18.73%Yahoo Finance
Price vs 50-dayTechnical-14.98%Yahoo Finance
Profit marginFinancial health14.43%Yahoo Finance
Quick ratioFinancial health1.08Yahoo Finance
Return on assetsFinancial health8.16%Yahoo Finance
Return on equityFinancial health16.51%Yahoo Finance
Return, 1 monthGrowth & momentum-18.40%Yahoo Finance
Return, 1 yearGrowth & momentum-27.05%Yahoo Finance
Return, 3 monthsGrowth & momentum-14.44%Yahoo Finance
Return, 3 yearsGrowth & momentum-5.43%Yahoo Finance
Return, 6 monthsGrowth & momentum-17.23%Yahoo Finance
Return, year to dateGrowth & momentum-22.11%Yahoo Finance
RevenueFinancial health$12.61BYahoo Finance
Revenue growthFinancial health9.40%Yahoo Finance
Risk categoryRiskHighYahoo Finance
RSI (14)Technical28.9Yahoo Finance
Shares outstandingValuation383,573,046Yahoo Finance
Sharpe ratioGrowth & momentum0.08Yahoo Finance
Stochastic %KTechnical5.2Yahoo Finance
Volatility, annualisedRisk25.69%Yahoo Finance
VolumeMarket data2,290,951Yahoo Finance
Win rateGrowth & momentum49.84%Yahoo Finance
Worst dayGrowth & momentum-8.81%Yahoo Finance
Add to portfolio Compare Peers Set a price target

Yahoo Finance via yfinance · delayed 15 minutes or more